Clin2
NCT06335043Possibly a fitRecruiting

Personalized medication matching for veterans with OSI

Pharmacogenetic Testing to Determine Pharmacological Treatment in PTSD

Part of Mental health clinical trials.

This trial tests whether using genetic information to guide medication choices can improve treatment for veterans with operational stress injuries (OSI). It aims to help find the right medication faster and with fewer side effects.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
155 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are a veteran (Canadian Armed Forces or RCMP member).
  • You are at least 18 years old.
  • You are currently a patient at the London St. Joseph's OSI Clinic.
  • You have a current diagnosis of an operational stress injury (OSI).
  • You speak and write English.
  • You agree to allow the use of your OSI Clinic records and CROMIS data for the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06035809Recruiting
Smart treatment study for PTSD using brain activity feedback

This study tests a new therapy called SMART, which uses brain imaging to help regulate arousal linked to PTSD. It aims to see if combining brain feedback with therapy reduces PTSD symptoms.

London, Ontario
NCT06568601Recruiting
Genetic testing to guide statin choice for veterans

This study looks at using a genetic test to help doctors choose the best statin medicine for veterans who need to lower their cholesterol but haven't taken a statin in the last 6 months. If you have diabetes, heart disease, or have had a stroke, this trial may help find a statin that works well for you with fewer side effects.

Indianapolis, Indiana
NCT07187011Not yet recruiting· Phase 2
Testing PT150 for PTSD in veterans

This trial tests a new oral medication, PT150, to see if it helps reduce PTSD symptoms in veterans. You must have had PTSD for at least 3 months and not be taking certain other medications.

San Diego, California
NCT04452500Recruiting· Phase 2
Study drug for PTSD symptoms in Veterans

This trial tests a study medicine that blocks the effects of cortisol (a stress hormone) to reduce PTSD symptoms in Veterans. It’s meant for people with ongoing PTSD symptoms and stable treatments, and it closely checks safety because the medicine can affect sleep, mood, and heart rhythm.

Tuscaloosa, Alabama
NCT07176273Recruiting
Personalized PTSD Treatment for Veterans

This trial helps veterans with PTSD choose between two proven talk therapies—Prolonged Exposure (PE) or Cognitive Processing Therapy (CPT)—and uses a smartphone app to support their treatment. The goal is to see which approach works best for each person.

Augusta, Georgia
NCT06788678Recruiting
Web-based moral elevation for veterans with PTSD

This trial tests a website designed to help veterans with PTSD feel inspired by stories of others' good deeds, which may reduce PTSD symptoms. You would complete sessions online and answer questions about your experiences.

Temple, Texas

Hear when a new Pharmacogenetic Testing to Determine Pharmacological Treatment in PTSD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.